1. Savytskyi IV, Ershova LA, Moiseieva G, Yermuraki P. Comparison of expenditure of using experimental models of carcinogenesis. Journal of Education, Health and Sport. 2020; 26;10(11):182-8. [
DOI:10.12775/JEHS.2020.10.11.017]
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Infection with Helicobacter pylori. In Schistosomes, Liver Flukes and Helicobacter pylori. International Agency for Research on Cancer. 1994.
3. Abdel,M.M.,Hassan,A.,and El-Sewedy,S.Human bladder cancer,schistosomiasis,N-nitroso compounds and their precursors. International Journal of Cancer.2000; 88,682-683
https://doi.org/10.1002/1097-0215(20001115)88:4<682::AID-IJC26>3.0.CO;2-E [
DOI:10.1002/1097-0215(20001115)88:43.0.CO;2-E] [
PMID]
4. Su Z., Yang Z., Xu Y., Chen Y., & Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Molecular cancer.2015; 14: 48. [
DOI:10.1186/s12943-015-0321-5] [
PMID] [
PMCID]
5. Abdel-Tawab GA, Aboul-Azm T, Ebied SA, el-Toukhy MA, Abdel-Hamied HA, el-Kholy ZA, el-Sharaky AS. The correlation between certain tryptophan metabolites and the N-nitrosamine content in the urine of bilharzial bladder cancer patients. Journal Urol. 1986; 135(4):826-30. [
DOI:10.1016/S0022-5347(17)45869-1] [
PMID]
6. Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Research. 1994; 54(7):1929s-33s.
7. Abe K.,Kagei N.,Teramura Y., Ejima H.Evidence for the segregation of a major gene in human susceptibility/resistance to infection by schistosoma mansoni. Journal of Medical Primatology.1993; 22: 237-239. [
DOI:10.1111/j.1600-0684.1993.tb00662.x] [
PMID]
8. Aji T, Matsuoka H, Ishii A, Arimoto S, Hayatsu H. Retention of a mutagen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), in the liver of mice infected with Schistosoma japonicum. Mutat Res. 1994; 305(2):265-72. [
DOI:10.1016/0027-5107(94)90246-1] [
PMID]
9. Amano T, Oshima T. Hepatoma formation in ddY mice with chronic schistosomiasis japonica. Japanese Journal of Cancer Research. 1988; 79(2):173-80. [
DOI:10.1111/j.1349-7006.1988.tb01574.x] [
PMID] [
PMCID]
10. Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. International Journal of Radiation OncologyBiology Physics. 2001; 49(2):427-33. [
DOI:10.1016/S0360-3016(00)01488-7] [
PMID]
11. Amono T.(1980).Clinicopathological studies on the gastrointestinal schistosomiasis in the endemic area of Yamanashi Prefecture with special refrence to the carcinogenicity of schistosome infection. Japanese Journal of Parasitology.1980; 29:305-312.
12. Andrade ZA., Abreu WN. Follicular lymphoma of the spleen in patients with hepatosplenic schistosomiasis mansoni. Mutation Research. 1971; 20: 237-243. [
DOI:10.4269/ajtmh.1971.20.237] [
PMID]
13. Armito S.,Matsuoka H.,Aji T.,Ishii A.,Wataya Y.,Hayatsu h.Modified metabolism of a carcinogen 3-amino-1-methyl-5H-pyrido[4,3-b]indole(Trp-P-2),by liver S9 from schistosoma japonica infected mice Mutation Research. 1992; 282:177-182. [
DOI:10.1016/0165-7992(92)90092-V] [
PMID]
14. Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, Fang YY. Clonorchiasis: a key foodborne zoonosis in China. The Lancet infectious diseases. 2005 ;5(1):31-41. [
DOI:10.1016/S1473-3099(04)01252-6] [
PMID]
15. Nakano S, Ueo H, Bruce SA, Ts'o PO. A contact-insensitive subpopulation in Syrian hamster cell cultures with a greater susceptibility to chemically induced neoplastic transformation. Proceedings of the National Academy of Sciences. 1985; 82(15):5005-9. [
DOI:10.1073/pnas.82.15.5005] [
PMID] [
PMCID]
16. Van Vugt F. The energy metabolism of the adult common liver fluke, Fasciola hepatica. Veterinary Science Communications. 1979 ;3:299-316. [
DOI:10.1007/BF02268980]
17. Badawi AF.Molecular and genetic events in schistosomiasis-associated human bladder cancer:Role of oncogenes and tumor suppressor genes. Cancer Letters.1996; 105,123-138. [
DOI:10.1016/0304-3835(96)04284-X] [
PMID]